Tag Archives: Aranesp
-
-
For-Profit Dialysis Centers May Have Ignored Anemia Drug Warnings: Study
-
Aranesp Fails to Help Heart Failure Patients in Clinical Trial
-
Aranesp Settlement Results in $762M Payment by Amgen
-
Drug Maker Overhyped, Oversold Anemia Meds: Report
-
Epogen, Aranesp Misuse Rampant: Study
-
Aranesp, Procrit and Epogen Health Risks Call For Lower Doses: FDA
-
Epogen, Procrit May Increase Heart Attack Damage: Study
-
Use of Anemia Drugs for Kidney Failure Supported by FDA Panel
-
Anemia Drugs Increase Risk of Heart Problems, Death in Some Cases: Study